Insulet Corp.
PODD
Classifica tra le azioni
#2094
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Prezzo delle azioni
$143.47
Capitalizzazione di mercato
$9.95B
Variazione (1 giorno)
1.06%
Variazione (1 anno)
-56.10%
Paese
US
Scambia Insulet Corp. (PODD)
Categoria
Healthcare
Ricavi di Insulet Corp. (PODD)
Ricavi nel Jun 2026 TTM: $3.05B
Secondo gli ultimi rapporti finanziari di Insulet Corp., i ricavi attuali dell'azienda (TTM) sono pari a $3.05B. Nel 2023, l'azienda ha registrato ricavi di $1.70B un aumento rispetto a i ricavi dell'anno 2022, che erano pari a $1.31B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Insulet Corp. da 2002 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $3.05B | 47.40% |
| 2024 | $2.07B | 22.07% |
| 2023 | $1.70B | 30.02% |
| 2022 | $1.31B | 18.79% |
| 2021 | $1.10B | 21.49% |
| 2020 | $904.40M | 22.51% |
| 2019 | $738.20M | 30.93% |
| 2018 | $563.82M | 21.57% |
| 2017 | $463.77M | 26.37% |
| 2016 | $366.99M | 39.07% |
| 2015 | $263.89M | -8.60% |
| 2014 | $288.72M | 16.85% |
| 2013 | $247.08M | 16.90% |
| 2012 | $211.37M | 38.83% |
| 2011 | $152.26M | 57.02% |
| 2010 | $96.97M | 46.85% |
| 2009 | $66.03M | 83.12% |
| 2008 | $36.06M | 169.66% |
| 2007 | $13.37M | 265.06% |
| 2006 | $3.66M | 7,226.00% |
| 2005 | $50.00K | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.59B | 1,425.63% |
US
|
|
| $35.48B | 1,062.08% |
IE
|
|
| $25.84B | 746.14% |
US
|
|
| $21.00B | 587.60% |
US
|
|
| - | - |
DE
|
